FutureWorld Corp. (FWDG)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Oct 15, 2025
FutureWorld Revenue
FutureWorld had revenue of $87.15K in the quarter ending December 31, 2016. This brings the company's revenue in the last twelve months to $251.68K, down -173.94% year-over-year.
Revenue (ttm)
251.68K
Revenue Growth
-173.94%
P/S Ratio
0.03
Revenue / Employee
31.46K
Employees
8
Market Cap
8.39K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2016 | - | - | - |
| Mar 31, 2015 | 90.01K | - | - |
| Mar 31, 2014 | - | - | - |
| Mar 31, 2013 | - | - | - |
| Mar 31, 2010 | - | - | - |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |